Lj. Krasner et al., DIRECT EFFECTS OF TRIIODOTHYRONINE ON HUMAN INTERNAL MAMMARY ARTERY AND SAPHENOUS VEINS, Journal of cardiothoracic and vascular anesthesia, 11(4), 1997, pp. 463-466
Citations number
24
Categorie Soggetti
Anesthesiology,"Peripheal Vascular Diseas","Cardiac & Cardiovascular System
Objective: Thyroid hormone [3,5,3'-triiodo-L-thyronine) is under inves
tigation as a positive inotrope and vasodilator for patients undergoin
g cardiac surgery. This study determined the direct effects of triiodo
thyronine on human blood vessels. Design: Prospective, controlled, in
vitro study. Setting: Laboratory facility in a university teaching hos
pital. Participants: Small excess segments of internal mammary arterie
s or saphenous Veins were obtained from patients undergoing coronary a
rtery bypass surgery. Interventions: Vessel segments were cut into rin
gs to measure isometric tension development in isolated tissue baths c
ontaining Krebs-Ringer bicarbonate solution at 37 degrees C. Rings wer
e prestretched in vitro to resting tensions analogous to mean arterial
or central Venous pressures in vivo and then constricted with potassi
um or phenylephrine. Rings were exposed to increasing concentrations o
f triiodothyronine (4 x 10(-12) to 1 x 10(-4) mol/L) to obtain dose-re
sponse curves. Measurements and Main Results: High concentrations (gre
ater than or equal to 3.3 x 10(-5) mol/L) of triiodothyronine produced
dose-dependent relaxation of preconstricted rings. The relaxation was
not selective for arteries or veins at arterial resting tensions, and
with either potassium or phenylephrine as a vasoconstrictor. Proprano
lol had little effect on subsequent triiodothyronine-induced relaxatio
n of potassium-constricted rings at resting arterial tensions. Conclus
ions: Triiodothyronine, in supraphysiological and suprapharmacological
concentrations, dilates preconstricted rings of human blood vessels i
n vitro; however, triiodothyronine had no demonstrable vasomotor effec
ts on human internal mammary artery or saphenous vein in clinically re
levant concentrations (10(-9) to 10(-8) mol/L). Triiodothyronine admin
istration in vivo most likely has little direct effect on the tone of
human vascular smooth muscle, particularly coronary artery bypass cond
uits. Copyright (C) 1997 by W.B. Saunders Company.